在阻塞性超性心肌病的发展中进行中枢改造
Francesco Moroni1, Abhishek Chaturvedi2, Ehsan Jafree2
1VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA; The Robert M Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, USA.
Indian heart journal
|June 22, 2023
概括
中心重塑有助于左心室外流通道阻塞 (LVOTO) 在多变性心肌病 (HCM). 较长的中枢片说明书预测了HCM患者随着时间的推移LVOTO的发展.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 医疗成像医学成像
背景情况:
- 超性心肌病 (HCM) 经常导致左心室外流通道阻塞 (LVOTO).
- mitra 门重塑在 HCM 中 LVOTO 的进展中的作用尚不清楚.
研究的目的:
- 调查美特拉改造对高性心肌病患者LVOTO发展的贡献.
主要方法:
- 在没有基线阻塞的40名HCM患者的回顾性分析.
- 平均随访时间为2179天.
- 评估中枢片片长度和LVOTO的发展.
主要成果:
- 在40名患者中,有13名患者在随访期间出现了显著的LVOTO.
- 患有LVOTO的患者有显著更长的后部叶片.
- 在患有发育LVOTO的患者中,也观察到较长的前侧叶片残留长度.
结论:
- 副心叶片的延长与HCM中LVOTO的进展有关.
- 这些发现表明,中枢改造是HCM阻塞发展的关键因素.
更多相关视频
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Mitral Stenosis I: Introduction
18
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Mitral Valve Prolapse I: Introduction
22
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
22
Mitral Regurgitation I: Introduction
19
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Mitral Regurgitation III: Medical Management
20
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20


